{"id":446725,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2020-12-21] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:40:48.772000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2020-12-21.html?wbdisable=false","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Date: December 21, 2020 Our file number: 20-117402-338 The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene…","rawSnapshotUrl":"/api/snapshots/raw/446725","browseUrl":"https://replay.healtharchive.ca/job-6/20260103124048/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2020-12-21.html?wbdisable=false#ha_snapshot=446725","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}